Consolidated Statements Of Cash Flows - USD ($) $ in Thousands	1 Months Ended	11 Months Ended	12 Months Ended
	Feb. 02, 2021	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2020
Cash flows from operating activities:
Net income (loss)	$ 268,777	$ (162,178)	$ 286,465	$ (396,230)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation, depletion, amortization and accretion	10,499	251,361	98,060	146,793
Right-of-use assets amortization	1,372	8,380	6,357	20,224
Deferred income taxes	54,322	(48,975)	(104,587)	2,041
Stock-based compensation expense	935	2,710	4,807	2,628
Reorganization items, net	(354,279)	0	0	18,087
Bad debt	(210)	(4,908)	2,248	12,473
Gain on sale of assets and businesses	58	0	0	0
Gain on sale of equity securities	0	(383)	(8,950)	0
Unrealized gain on investment in equity securities	0	(2,147)	0	0
Other (gains) and losses, net	0	30,707	(32,872)	141,110
Other reconciling items, net	(355)	6,687	(3,822)	(8,309)
Changes in operating assets and liabilities:
Accounts receivable	3,602	(28,676)	(65,669)	111,948
Prepaid expense	(340)	4,854	(1,096)	0
Inventory and other current assets	(221)	22,866	(4,568)	27,933
Accounts payable	(2,365)	735	(10,149)	(35,170)
Accrued expenses	23,489	(21,770)	8,503	(18,154)
Income taxes	340	11,535	771	0
Other, net	(241)	(11,914)	(82)	(23,157)
Net cash from operating activities	5,383	58,884	175,416	2,217
Cash flows from investing activities:
Payments for capital expenditures	(3,035)	(34,152)	(65,784)	(47,653)
Proceeds from sales of assets	775	97,505	50,376	50,039
Proceeds from sales of equity securities	0	4,099	34,685	0
Net cash from investing activities	(2,260)	67,452	19,277	2,386
Cash flows from financing activities:
Credit facility costs	(1,920)	(14)	0	(1,554)
Tax withholdings for vested restricted stock units	0	(1,485)	(135)	(208)
Distributions to shareholders	0	0	(249,986)	0
Other	0	0	0	(12,432)
Net cash from financing activities	(1,920)	(1,499)	(250,121)	(14,194)
Effect of exchange rate changes on cash	311	0	0	2,387
Net change in cash, cash equivalents, and restricted cash	1,514	124,837	(55,428)	(7,204)
Cash, cash equivalents, and restricted cash beginning of period	268,184	269,698	394,535	275,388
Cash, cash equivalents, and restricted cash at end of period	$ 269,698	$ 394,535	$ 339,107	$ 268,184